OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on September 14, 2018. The report addresses a specific corporate event regarding the status of the Company's common stock on The Nasdaq Stock Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a market event and does not contain financial statements or performance metrics.
Material Changes
The primary material event reported is the resumption of trading in OPKO Health, Inc.'s common stock on The Nasdaq Stock Market. Trading resumed on September 14, 2018, at 1:15 Eastern Daylight Time.
Guidance, Outlook, and Risks
The filing includes a press release (Exhibit 99.1) regarding the resumption of trading. The document explicitly states that the information contained in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. No forward-looking guidance, management commentary on financial outlook, or specific risk factors are detailed within the body of this 8-K text.
Investor Verification Checklist
- Verify the exact time trading resumed (1:15 EDT on September 14, 2018).
- Review the full text of the press release attached as Exhibit 99.1 for context on the trading suspension and resumption.
- Confirm that no financial data is included in this specific filing and refer to the most recent 10-Q or 10-K for financial metrics.